Literature DB >> 19329542

A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.

Eileen Workman1, Luciano Saieva, Tessa L Carrel, Thomas O Crawford, Don Liu, Cathleen Lutz, Christine E Beattie, Livio Pellizzoni, Arthur H M Burghes.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease. Loss of the survival motor neuron (SMN1) gene, in the presence of the SMN2 gene causes SMA. SMN functions in snRNP assembly in all cell types, however, it is unclear how this function results in specifically motor neuron cell death. Lack of endogenous mouse SMN (Smn) in mice results in embryonic lethality. Introduction of two copies of human SMN2 results in a mouse with severe SMA, while one copy of SMN2 is insufficient to overcome embryonic lethality. We show that SMN(A111G), an allele capable of snRNP assembly, can rescue mice that lack Smn and contain either one or two copies of SMN2 (SMA mice). The correction of SMA in these animals was directly correlated with snRNP assembly activity in spinal cord, as was correction of snRNA levels. These data support snRNP assembly as being the critical function affected in SMA and suggests that the levels of snRNPs are critical to motor neurons. Furthermore, SMN(A111G) cannot rescue Smn-/- mice without SMN2 suggesting that both SMN(A111G) and SMN from SMN2 undergo intragenic complementation in vivo to function in heteromeric complexes that have greater function than either allele alone. The oligomer composed of limiting full-length SMN and SMN(A111G) has substantial snRNP assembly activity. Also, the SMN(A2G) and SMN(A111G) alleles in vivo did not complement each other leading to the possibility that these mutations could affect the same function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329542      PMCID: PMC2685758          DOI: 10.1093/hmg/ddp157

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  73 in total

1.  The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding.

Authors:  P J Young; N T Man; C L Lorson; T T Le; E J Androphy; A H Burghes; G E Morris
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

2.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

Authors:  B Schrank; R Götz; J M Gunnersen; J M Ure; K V Toyka; A G Smith; M Sendtner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Towards a model to explain the intragenic complementation in the heteromultimeric protein propionyl-CoA carboxylase.

Authors:  Pilar Rodríguez-Pombo; Celia Pérez-Cerdá; Belén Pérez; Lourdes R Desviat; Luis Sánchez-Pulido; Magdalena Ugarte
Journal:  Biochim Biophys Acta       Date:  2004-11-02

4.  Correlation between severity and SMN protein level in spinal muscular atrophy.

Authors:  S Lefebvre; P Burlet; Q Liu; S Bertrandy; O Clermont; A Munnich; G Dreyfuss; J Melki
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

5.  A comprehensive interaction map of the human survival of motor neuron (SMN) complex.

Authors:  Simon Otter; Matthias Grimmler; Nils Neuenkirchen; Ashwin Chari; Albert Sickmann; Utz Fischer
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

6.  Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.

Authors:  Dong P Liu; Cecilia Schmidt; Timothy Billings; Muriel T Davisson
Journal:  Biotechniques       Date:  2003-12       Impact factor: 1.993

7.  Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.

Authors:  Honglai L Zhang; Feng Pan; Daewha Hong; Shailesh M Shenoy; Robert H Singer; Gary J Bassell
Journal:  J Neurosci       Date:  2003-07-23       Impact factor: 6.167

8.  A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy.

Authors:  E Humphrey; L T Lam; H R Fuller; T A Lynch; C A Sewry; P R Goodwin; A E Mackenzie; G E Morris
Journal:  Neurology       Date:  2008-07-16       Impact factor: 9.910

Review 9.  Chaperoning ribonucleoprotein biogenesis in health and disease.

Authors:  Livio Pellizzoni
Journal:  EMBO Rep       Date:  2007-04       Impact factor: 8.807

10.  A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.

Authors:  Umrao R Monani; Matthew T Pastore; Tatiana O Gavrilina; Sibylle Jablonka; Thanh T Le; Catia Andreassi; Jennifer M DiCocco; Christian Lorson; Elliot J Androphy; Michael Sendtner; Michael Podell; Arthur H M Burghes
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  55 in total

Review 1.  Spinal muscular atrophy: new and emerging insights from model mice.

Authors:  Gyu-Hwan Park; Shingo Kariya; Umrao R Monani
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 2.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

3.  Antisense oligonucleotides and spinal muscular atrophy: skipping along.

Authors:  Arthur H M Burghes; Vicki L McGovern
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

Review 4.  Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy.

Authors:  Eileen Workman; Stephen J Kolb; Daniel J Battle
Journal:  Brain Res       Date:  2012-02-28       Impact factor: 3.252

5.  Temporal requirement for high SMN expression in SMA mice.

Authors:  Thanh T Le; Vicki L McGovern; Isaac E Alwine; Xueyong Wang; Aurelie Massoni-Laporte; Mark M Rich; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2011-06-13       Impact factor: 6.150

6.  An SMN-dependent U12 splicing event essential for motor circuit function.

Authors:  Francesco Lotti; Wendy L Imlach; Luciano Saieva; Erin S Beck; Le T Hao; Darrick K Li; Wei Jiao; George Z Mentis; Christine E Beattie; Brian D McCabe; Livio Pellizzoni
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

7.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

8.  Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs.

Authors:  Till Geib; Klemens J Hertel
Journal:  PLoS One       Date:  2009-12-08       Impact factor: 3.240

9.  A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2.

Authors:  Francine M Jodelka; Allison D Ebert; Dominik M Duelli; Michelle L Hastings
Journal:  Hum Mol Genet       Date:  2010-09-30       Impact factor: 6.150

Review 10.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.